From: Bloomberg
By Alex Ruoff
Sen. Marco Rubio (R-Fla.) wants to know if Medicare is giving China an advantage over U.S. biotechnology firms and hopes to direct the government to see how often Americans’ genetic data goes overseas.
Rubio convinced his colleagues in Congress to include a provision in the latest spending bill to investigate how much federal funding goes to Chinese and Russian companies that analyze the DNA of Medicare and Medicaid beneficiaries. The Labor, Health and Human Services, Education, and Related Agencies spending bill passed the full Senate Aug. 23
Leave a Reply